Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11568762rdf:typepubmed:Citationlld:pubmed
pubmed-article:11568762lifeskim:mentionsumls-concept:C0004604lld:lifeskim
pubmed-article:11568762lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11568762lifeskim:mentionsumls-concept:C0069751lld:lifeskim
pubmed-article:11568762lifeskim:mentionsumls-concept:C0031928lld:lifeskim
pubmed-article:11568762pubmed:issue4lld:pubmed
pubmed-article:11568762pubmed:dateCreated2001-9-24lld:pubmed
pubmed-article:11568762pubmed:abstractTextNotalgia paresthetica is a sensory neuropathy typically presenting with pruritus on the back. There is currently no effective treatment for this disorder. We describe a single patient who responded to oxcarbazepine, and a subsequent trial in another 4 who also responded. Although the number of patients in our study is small, we believe further trials are warranted to determine the efficacy of oxcarbazepine in this disorder.lld:pubmed
pubmed-article:11568762pubmed:languageenglld:pubmed
pubmed-article:11568762pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11568762pubmed:citationSubsetIMlld:pubmed
pubmed-article:11568762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11568762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11568762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11568762pubmed:statusMEDLINElld:pubmed
pubmed-article:11568762pubmed:monthOctlld:pubmed
pubmed-article:11568762pubmed:issn0190-9622lld:pubmed
pubmed-article:11568762pubmed:authorpubmed-author:SaviGGlld:pubmed
pubmed-article:11568762pubmed:authorpubmed-author:AkyolAAlld:pubmed
pubmed-article:11568762pubmed:authorpubmed-author:BolukbasiOOlld:pubmed
pubmed-article:11568762pubmed:authorpubmed-author:KaramanGGlld:pubmed
pubmed-article:11568762pubmed:issnTypePrintlld:pubmed
pubmed-article:11568762pubmed:volume45lld:pubmed
pubmed-article:11568762pubmed:ownerNLMlld:pubmed
pubmed-article:11568762pubmed:authorsCompleteYlld:pubmed
pubmed-article:11568762pubmed:pagination630-2lld:pubmed
pubmed-article:11568762pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11568762pubmed:meshHeadingpubmed-meshheading:11568762...lld:pubmed
pubmed-article:11568762pubmed:meshHeadingpubmed-meshheading:11568762...lld:pubmed
pubmed-article:11568762pubmed:meshHeadingpubmed-meshheading:11568762...lld:pubmed
pubmed-article:11568762pubmed:meshHeadingpubmed-meshheading:11568762...lld:pubmed
pubmed-article:11568762pubmed:meshHeadingpubmed-meshheading:11568762...lld:pubmed
pubmed-article:11568762pubmed:meshHeadingpubmed-meshheading:11568762...lld:pubmed
pubmed-article:11568762pubmed:meshHeadingpubmed-meshheading:11568762...lld:pubmed
pubmed-article:11568762pubmed:meshHeadingpubmed-meshheading:11568762...lld:pubmed
pubmed-article:11568762pubmed:meshHeadingpubmed-meshheading:11568762...lld:pubmed
pubmed-article:11568762pubmed:year2001lld:pubmed
pubmed-article:11568762pubmed:articleTitleOpen pilot study on oxcarbazepine for the treatment of notalgia paresthetica.lld:pubmed
pubmed-article:11568762pubmed:affiliationDepartment of Dermatology, Adnan Menderes University Faculty of Medicine, Aydin, Turkey.lld:pubmed
pubmed-article:11568762pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11568762pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11568762lld:pubmed